Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...
Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...
MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can ...
In a new paper presented at IEDM 2025, imec reports on the successful fabrication of highly uniform nanopores with diameters ...
Terns Pharmaceuticals, Inc. ( TERN) Discusses Efficacy and Safety Data Update for TERN-701 in Chronic Myeloid Leukemia December 8, 2025 4:30 PM EST ...
MS. COOPER: Good morning, and welcome to The Washington Post. I’m Gina Cooper, managing director of Washington Post Live. Thank you so much to everyone who’s here in the room joining us this morning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback